Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of AIR DNAse Administered by Inhalation to Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability and pharmacokinetics of inhaled AIR DNAse in healthy adult volunteers is reported, sponsored by Protalix.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• AIR DNAse (deoxyribonuclease)

Snippet

Sponsor: Protalix | Conditions: Cystic Fibrosis (CF) | Phase 1 | Status: COMPLETED